The mucosal immune system for vaccine development

Vaccine

Volumn 32, Issue 49, 2014, Pages 6711-6723

  Lamichhane, Aayam ^a   Azegami, Tatsuhiko ^a,b   Kiyono, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

GALT; M cell; MALT; MucoRice; NALT; Peyer's patch

Indexed keywords

BACTERIAL TOXIN; CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; VACCINE;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNIZATION; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE; MICROFLORA; MUCORICE; MUCOSA ASSOCIATED LYMPHOID TISSUE; MUCOSAL IMMUNITY; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RICE; TEAR DUCT ASSOCIATED LYMPHOID TISSUE; TH1 CELL; TH2 CELL; BIOTECHNOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MUCOSAL DRUG ADMINISTRATION; PHARMACEUTICS; PROCEDURES; TRANSGENIC PLANT; TRENDS;

ADMINISTRATION, MUCOSAL; BIOTECHNOLOGY; HUMANS; IMMUNITY, MUCOSAL; PLANTS, GENETICALLY MODIFIED; TECHNOLOGY, PHARMACEUTICAL; VACCINES;

EID: 84922592038     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.089     Document Type: Review

References (170)

1. Neutra M.R., Pringault E., Kraehenbuhl J.P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996, 14:275-300.
2. Kiyono H., Kunisawa J., McGhee J.R., Mestecky J. The mucosal immune system. Fundamental immunology 2008, 983-1030. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA.
3. Kato T., Owen R.L. Structure and function of intestinal mucosal epithelium. Mucosal immunology 2005, 131-153. Elsevier Academic Press, Amsterdam; Boston.
4. Peters B.M., Shirtliff M.E., Jabra-Rizk M.A. Antimicrobial peptides: primeval molecules or future drugs?. PLoS Pathog 2010, 6(10):e1001067.
5. McGhee J.R., Michalek S.M., Kiyono H., Eldridge J.H., Colwell D.E., Williamson S.I., et al. Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response. Microbiol Immunol 1984, 28(3):261-280.
6. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(2):148-158.
7. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292(5519):1115-1118.
8. Kiyono H., Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004, 4(9):699-710.
9. Yuki Y., Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 2003, 13(5):293-310.
10. Owen R.L., Jones A.L. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974, 66(2):189-203.
11. Neutra M.R.K.J.P. Cellular and molecular basis for antigen transport across epitherial barriers. Mucosal Immunology 2005, 111-130. Academic Press, Burlington.
12. Wolf J.L., Rubin D.H., Finberg R., Kauffman R.S., Sharpe A.H., Trier J.S., et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science 1981, 212(4493):471-472.
13. Kelsall B.L., Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996, 183(1):237-247.
14. Sato A., Iwasaki A. Peyer's patch dendritic cells as regulators of mucosal adaptive immunity. Cell Mol Life Sci 2005, 62(12):1333-1338.
15. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314(5802):1157-1160.
16. Fagarasan S., Kawamoto S., Kanagawa O., Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 2010, 28:243-273.
17. Mestecky J., McGhee J.R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987, 40:153-245.
18. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008, 8(6):421-434.
19. Beagley K.W., Eldridge J.H., Kiyono H., Everson M.P., Koopman W.J., Honjo T., et al. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol 1988, 141(6):2035-2042.
20. Beagley K.W., Eldridge J.H., Lee F., Kiyono H., Everson M.P., Koopman W.J., et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989, 169(6):2133-2148.
21. Corthesy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 2013, 12(6):661-665.
22. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., et al. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int Immunol 1999, 11(5):643-655.
23. Mebius R.E., Rennert P., Weissman I.L. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7(4):493-504.
24. Browning J.L., Ngam-ek A., Lawton P., DeMarinis J., Tizard R., Chow E.P., et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72(6):847-856.
25. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., Luz A., Turetskaya R.L., Tarakhovsky A., et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 1997, 94(17):9302-9307.
26. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998, 9(1):59-70.
27. Koni P.A., Sacca R., Lawton P., Browning J.L., Ruddle N.H., Flavell R.A. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997, 6(4):491-500.
28. Yamamoto M., Rennert P., McGhee J.R., Kweon M.N., Yamamoto S., Dohi T., et al. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J Immunol 2000, 164(10):5184-5191.
29. Honda K., Nakano H., Yoshida H., Nishikawa S., Rennert P., Ikuta K., et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med 2001, 193(5):621-630.
30. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288(5475):2369-2373.
31. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397(6721):702-706.
32. Eberl G., Marmon S., Sunshine M.J., Rennert P.D., Choi Y., Littman D.R. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004, 5(1):64-73.
33. Kiyono H., McGhee J.R., Wannemuehler M.J., Frangakis M.V., Spalding D.M., Michalek S.M., et al. In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch. Proc Natl Acad Sci USA 1982, 79(2):596-600.
34. Frangakis M.V., Koopman W.J., Kiyono H.S., Michalek M., McGhee J.R. An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods 1982, 48(1):33-44.
35. Kunisawa J., Kurashima Y., Kiyono H. Gut-associated lymphoid tissues for the development of oral vaccines. Adv Drug Delivery Rev 2012, 64(6):523-530.
36. Hamada H., Hiroi T., Nishiyama Y., Takahashi H., Masunaga Y., Hachimura S., et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002, 168(1):57-64.
37. Tsuji M., Suzuki K., Kitamura H., Maruya M., Kinoshita K., Ivanov I.I., et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008, 29(2):261-271.
38. Fukuyama S., Hiroi T., Yokota Y., Rennert P.D., Yanagita M., Kinoshita N., et al. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity 2002, 17(1):31-40.
39. Rangel-Moreno J., Moyron-Quiroz J., Kusser K., Hartson L., Nakano H., Randall T.D. Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue. J Immunol 2005, 175(8):4904-4913.
40. Fukuyama S., Nagatake T., Kim D.Y., Takamura K., Park E.J., Kaisho T., et al. Cutting edge: uniqueness of lymphoid chemokine requirement for the initiation and maturation of nasopharynx-associated lymphoid tissue organogenesis. J Immunol 2006, 177(7):4276-4280.
41. Harmsen A., Kusser K., Hartson L., Tighe M., Sunshine M.J., Sedgwick J.D., et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent. J Immunol 2002, 168(3):986-990.
42. Tanaka N., Fukuyama S., Fukuiwa T., Kawabata M., Sagara Y., Ito H.O., et al. Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice. Vaccine 2007, 25(14):2680-2687.
43. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(4 Suppl.):S45-S53.
44. Johansson E.L., Wassen L., Holmgren J., Jertborn M., Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001, 69(12):7481-7486.
45. Nakamura Y., Sotozono C., Kinoshita S. Inflammatory cytokines in normal human tears. Curr Eye Res 1998, 17(6):673-676.
46. Gupta A., Monroy D., Ji Z., Yoshino K., Huang A., Pflugfelder S.C. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res 1996, 15(6):605-614.
47. McDermott A.M. Antimicrobial compounds in tears. Exp Eye Res 2013, 117:53-61.
48. Allansmith M.R., Radl J.J., Haaijman J., Mestecky J. Molecular forms of tear IgA and distribution of IgA subclasses in human lacrimal glands. J Allergy Clin Immunol 1985, 76(4):569-576.
49. Nagatake T., Fukuyama S., Kim D.Y., Goda K., Igarashi O., Sato S., et al. Id2-RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity. J Exp Med 2009, 206(11):2351-2364.
50. Okada K., Yamasoba T., Kiyono H. Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine. Adv Otorhinolaryngol 2011, 72:31-36.
51. Knop N., Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000, 41(6):1270-1279.
52. Knop E., Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci 2001, 42(3):566-574.
53. Ridley Lathers D.M., Gill R.F., Montgomery P.C. Inductive pathways leading to rat tear IgA antibody responses. Invest Ophthalmol Vis Sci 1998, 39(6):1005-1011.
54. Kaetzel C.S. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 2005, 206:83-99.
55. Woodrow K.A., Bennett K.M., Lo D.D. Mucosal vaccine design and delivery. Annu Rev Biomed Eng 2012, 14:17-46.
56. Bazin H., Levi G., Doria G. Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol 1970, 105(4):1049-1051.
57. Husband A.J., Gowans J.L. The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J Exp Med 1978, 148(5):1146-1160.
58. Elson C.O., Heck J.A., Strober W. T-cell regulation of murine IgA synthesis. J Exp Med 1979, 149(3):632-643.
59. McGhee J.R., Mestecky J., Elson C.O., Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989, 9(3):175-199.
60. Kiyono H., Cooper M.D., Kearney J.F., Mosteller L.M., Michalek S.M., Koopman W.J., et al. Isotype specificity of helper T cell clones, Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med 1984, 159(3):798-811.
61. Spalding D.M., Williamson S.I., Koopman W.J., McGhee J.R. Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J Exp Med 1984, 160(3):941-946.
62. Kawanishi H., Saltzman L.E., Strober W. Characteristics and regulatory function of murine con A-induced, cloned T cells obtained from Peyer's patches and spleen: mechanisms regulating isotype-specific immunoglobulin production by Peyer's patch B cells. J Immunol 1982, 129(2):475-483.
63. Kawanishi H., Saltzman L., Strober W. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues, II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells. J Exp Med 1983, 158(3):649-669.
64. Kiyono H., McGhee J.R. Th Cell Regulation of the IgA Response. Handbook of mucosal immunology 1994, Academic Press, Inc, San Diego,CA, pxxi, 766 p.
65. Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991, 173(3):705-710.
66. Coffman R.L., Seymour B.W., Lebman D.A., Hiraki D.D., Christiansen J.A., Shrader B., et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988, 102:5-28.
67. Hill D.A., Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010, 28:623-667.
68. Hapfelmeier S., Macpherson A.J. In remembrance of commensal intestinal microbes. Commun Integr Biol 2010, 3(6):569-571.
69. Bauer H., Horowitz R.E., Levenson S.M., Popper H. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol 1963, 42:471-483.
70. Macpherson A.J., Hunziker L., McCoy K., Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 2001, 3(12):1021-1035.
71. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122(1):107-118.
72. Falk P.G., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62(4):1157-1170.
73. Bouskra D., Brezillon C., Berard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456(7221):507-510.
74. Ohnmacht C., Marques R., Presley L., Sawa S., Lochner M., Eberl G. Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity. Cell Microbiol 2011, 13(5):653-659.
75. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291(5505):881-884.
76. Stappenbeck T.S., Hooper L.V., Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002, 99(24):15451-15455.
77. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009, 10(1):83-91.
78. Smith M.W., James P.S., Tivey D.R. M cell numbers increase after transfer of SPF mice to a normal animal house environment. Am J Pathol 1987, 128(3):385-389.
79. Savidge T.C., Smith M.W., James P.S., Aldred P. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am J Pathol 1991, 139(1):177-184.
80. Kiyono H., McGhee J.R., Michalek S.M. Lipopolysaccharide regulation of the immune response: comparison of responses to LPS in germfree, Escherichia coli-monoassociated and conventional mice. J Immunol 1980, 124(1):36-41.
81. Faria A.M., Weiner H.L. Oral tolerance. Immunol Rev 2005, 206:232-259.
82. Suzuki I., Kiyono H., Kitamura K., Green D.R., McGhee J.R. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory T-cell networks in the mucosal immune system. Nature 1986, 320(6061):451-454.
83. Fujihashi K., Taguchi T., Aicher W.K., McGhee J.R., Bluestone J.A., Eldridge J.H., et al. Immunoregulatory functions for murine intraepithelial lymphocytes: gamma/delta T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while alpha/beta TCR+ T cells provide B cell help. J Exp Med 1992, 175(3):695-707.
84. Fujihashi K., Dohi T., Rennert P.D., Yamamoto M., Koga T., Kiyono H., et al. Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci USA 2001, 98(6):3310-3315.
85. Kiyono H., McGhee J.R., Wannemuehler M.J., Michalek S.M. Lack of oral tolerance in C3H/HeJ mice. J Exp Med 1982, 155(2):605-610.
86. Wannemuehler M.J., Kiyono H., Babb J.L., Michalek S.M., McGhee J.R. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol 1982, 129(3):959-965.
87. Michalek S.M., Kiyono H., Wannemuehler M.J., Mosteller L.M., McGhee J.R. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 1982, 128(5):1992-1998.
88. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997, 159(4):1739-1745.
89. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453(7195):620-625.
90. Ochoa-Reparaz J., Mielcarz D.W., Haque-Begum S., Kasper L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010, 1(2):103-108.
91. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331(6015):337-341.
92. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31(4):677-689.
93. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139(3):485-498.
94. Umesaki Y., Setoyama H., Matsumoto S., Imaoka A., Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 1999, 67(7):3504-3511.
95. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504(7480):446-450.
96. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504(7480):451-455.
97. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007, 104(34):13780-13785.
98. Wei B., Su T.T., Dalwadi H., Stephan R.P., Fujiwara D., Huang T.T., et al. Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur J Immunol 2008, 38(12):3411-3425.
99. Wesemann D.R., Portuguese A.J., Meyers R.M., Gallagher M.P., Cluff-Jones K., Magee J.M., et al. Microbial colonization influences early B-lineage development in the gut lamina propria. Nature 2013, 501(7465):112-115.
100. Obata T., Goto Y., Kunisawa J., Sato S., Sakamoto M., Setoyama H., et al. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci USA 2010, 107(16):7419-7424.
101. Sonnenberg G.F., Monticelli L.A., Alenghat T., Fung T.C., Hutnick N.A., Kunisawa J., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336(6086):1321-1325.
102. Thorburn A.N., Macia L., Mackay C.R. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014, 40(6):833-842.
103. Kraehenbuhl J.P., Neutra M.R. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000, 16:301-332.
104. Bockman D.E., Cooper M.D. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am J Anat 1973, 136(4):455-477.
105. Nicoletti C. Unsolved mysteries of intestinal M cells. Gut 2000, 47(5):735-739.
106. Siebers A., Finlay B.B. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol 1996, 4(1):22-29.
107. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches. Histochem J 1994, 26(3):271-280.
108. Kandori H., Hirayama K., Takeda M., Doi K. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim 1996, 45(2):155-160.
109. Nochi T., Yuki Y., Matsumura A., Mejima M., Terahara K., Kim D.Y., et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007, 204(12):2789-2796.
110. Hase K., Kawano K., Nochi T., Pontes G.S., Fukuda S., Ebisawa M., et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009, 462(7270):226-230.
111. Terahara K., Yoshida M., Igarashi O., Nochi T., Pontes G.S., Hase K., et al. Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. J Immunol 2008, 180(12):7840-7846.
112. Pickard J.M., Chervonsky A.V. Sampling of the intestinal microbiota by epithelial M cells. Curr Gastroenterol Rep 2010, 12(5):331-339.
113. Golovkina T.V., Shlomchik M., Hannum L., Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science 1999, 286(5446):1965-1968.
114. Knoop K.A., Kumar N., Butler B.R., Sakthivel S.K., Taylor R.T., Nochi T., et al. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol 2009, 183(9):5738-5747.
115. Kanaya T., Hase K., Takahashi D., Fukuda S., Hoshino K., Sasaki I., et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol 2012, 13(8):729-736.
116. Sato S., Kaneto S., Shibata N., Takahashi Y., Okura H., Yuki Y., et al. Transcription factor Spi-B-dependent and -independent pathways for the development of Peyer's patch M cells. Mucosal Immunol 2013, 6(4):838-846.
117. Jang M.H., Kweon M.N., Iwatani K., Yamamoto M., Terahara K., Sasakawa C., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004, 101(16):6110-6115.
118. Schulz O., Pabst O. Antigen sampling in the small intestine. Trends Immunol 2013, 34(4):155-161.
119. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307(5707):254-258.
120. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2(4):361-367.
121. Park H.S., Francis K.P., Yu J., Cleary P.P. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 2003, 171(5):2532-2537.
122. Wu Y., Wang X., Csencsits K.L., Haddad A., Walters N., Pascual D.W. M cell-targeted DNA vaccination. Proc Natl Acad Sci USA 2001, 98(16):9318-9323.
123. Kim D.Y., Sato A., Fukuyama S., Sagara H., Nagatake T., Kong I.G., et al. The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens. J Immunol 2011, 186(7):4253-4262.
124. Ogra P.L., Faden H., Welliver R.C. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001, 14(2):430-445.
125. Ohmura M., Yamamoto M., Tomiyama-Miyaji C., Yuki Y., Takeda Y., Kiyono H. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Infect Immun 2005, 73(7):4088-4097.
126. Nochi T., Takagi H., Yuki Y., Yang L., Masumura T., Mejima M., et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci USA 2007, 104(26):10986-10991.
127. Holmgren J., Czerkinsky C., Eriksson K., Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 2003, 21(Suppl. 2):S89-S95.
128. Ogra P.L., Karzon D.T., Righthand F., MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 1968, 279(17):893-900.
129. Kunisawa J., Nochi T., Kiyono H. Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol 2008, 29(11):505-513.
130. Azegami T., Yuki Y., Kiyono H. Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol 2014, 26(9):517-528.
131. Kayama H., Takeda K. Regulation of intestinal homeostasis by innate and adaptive immunity. Int Immunol 2012, 24(11):673-680.
132. Freytag L.C., Clements J.D. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 1999, 236:215-236.
133. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993, 178(4):1309-1320.
134. Elson C.O., Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984, 132(6):2736-2741.
135. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350(9):896-903.
136. Douce G., Giannelli V., Pizza M., Lewis D., Everest P., Rappuoli R., et al. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants. Infect Immun 1999, 67(9):4400-4406.
137. Ryan E.J., McNeela E., Murphy G.A., Stewart H., O'Hagan D., Pizza M., et al. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun 1999, 67(12):6270-6280.
138. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Fujihashi K., Van Ginkel F.W., et al. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997, 94(10):5267-5272.
139. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Fujihashi K., et al. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med 1997, 185(7):1203-1210.
140. Eriksson K., Fredriksson M., Nordstrom I., Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect Immun 2003, 71(4):1740-1747.
141. Pizza M., Fontana M.R., Giuliani M.M., Domenighini M., Magagnoli C., Giannelli V., et al. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med 1994, 180(6):2147-2153.
142. Giannelli V., Fontana M.R., Giuliani M.M., Guangcai D., Rappuoli R., Pizza M. Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. Infect Immun 1997, 65(1):331-334.
143. Lewis D.J., Huo Z., Barnett S., Kromann I., Giemza R., Galiza E., et al. Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One 2009, 4(9):e6999.
144. Kweon M.N., Yamamoto M., Watanabe F., Tamura S., Van Ginkel F.W., Miyauchi A., et al. A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis 2002, 186(9):1261-1269.
145. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012, 12(8):592-605.
146. Uematsu S., Fujimoto K., Jang M.H., Yang B.G., Jung Y.J., Nishiyama M., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 2008, 9(7):769-776.
147. Thanavala Y., Mahoney M., Pal S., Scott A., Richter L., Natarajan N., et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA 2005, 102(9):3378-3382.
148. Li J.T., Fei L., Mou Z.R., Wei J., Tang Y., He H.Y., Wang L., Wu Y.Z. Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 2006, 356(1-2):171-178.
149. Zhang X., Buehner N.A., Hutson A.M., Estes M.K., Mason H.S. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 2006, 4(4):419-432.
150. Santi L., Giritch A., Roy C.J., Marillonnet S., Klimyuk V., Gleba Y., et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 2006, 103(4):861-866.
151. Moravec T., Schmidt M.A., Herman E.M., Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 2007, 25(9):1647-1657.
152. Jiang X.L., He Z.M., Peng Z.Q., Qi Y., Chen Q., Yu S.Y. Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice. Transgenic Res 2007, 16(2):169-175.
153. Rosales-Mendoza S., Soria-Guerra R.E., Lopez-Revilla R., Moreno-Fierros L., Alpuche-Solis A.G. Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 2008, 27(1):79-84.
154. Yuki Y., Tokuhara D., Nochi T., Yasuda H., Mejima M., Kurokawa S., et al. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine 2009, 27(43):5982-5988.
155. Nochi T., Yuki Y., Katakai Y., Shibata H., Tokuhara D., Mejima M., et al. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. J Immunol 2009, 183(10):6538-6544.
156. Tokuhara D., Yuki Y., Nochi T., Kodama T., Mejima M., Kurokawa S., et al. Secretory IgA-mediated protection against V. Cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci USA 2010, 107(19):8794-8799.
157. Yuki Y., Mejima M., Kurokawa S., Hiroiwa T., Kong I.G., Kuroda M., et al. RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine. Vaccine 2012, 30(28):4160-4166.
158. Yuki Y., Mejima M., Kurokawa S., Hiroiwa T., Takahashi Y., Tokuhara D., et al. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification. Plant Biotechnol J 2013, 11(7):799-808.
159. Kurokawa S., Nakamura R., Mejima M., Kozuka-Hata H., Kuroda M., Takeyama N., et al. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of alpha-amylase/trypsin inhibitor-like protein family as major rice allergens. J Proteome Res 2013, 12(7):3372-3382.
160. Tokuhara D., Alvarez B., Mejima M., Hiroiwa T., Takahashi Y., Kurokawa S., et al. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest 2013, 123(9):3829-3838.
161. Kurokawa S., Kuroda M., Mejima M., Nakamura R., Takahashi Y., Sagara H., et al. RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds. Plant Cell Rep 2014, 33(1):75-87.
162. Abe M., Yuki Y., Kurokawa S., Mejima M., Kuroda M., Park E.J., et al. A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice. J Biotechnol 2014, 175:45-52.
163. Abba K., Sinfield R., Hart C.A., Garner P. Pathogens associated with persistent diarrhoea in children in low and middle income countries: systematic review. BMC Infect Dis 2009, 9(88).
164. Belshe R., Lee M.S., Walker R.E., Stoddard J., Mendelman P.M. Safety immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines 2004, 3(6):643-654.
165. Lavelle E.C. Generation of improved mucosal vaccines by induction of innate immunity. Cell Mol Life Sci 2005, 62(23):2750-2770.
166. van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000, 165(9):4778-4782.
167. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Adv Drug Delivery Rev 2008, 60(8):915-928.
168. Sharma S., Mukkur T.K., Benson H.A., Chen Y. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems. J Pharm Sci 2009, 98(3):812-843.
169. Nochi T., Yuki Y., Takahashi H., Sawada S., Mejima M., Kohda T., et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010, 9(7):572-578.
170. Kong I.G., Sato A., Yuki Y., Nochi T., Takahashi H., Sawada S., et al. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae. Infect Immun 2013, 81(5):1625-1634.